Literature DB >> 19602068

Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?

Helmut Beltraminelli1, Robert Müllegger, Lorenzo Cerroni.   

Abstract

BACKGROUND: Recently, Petrella et al. described four patients with an unusual CD8+ lymphoid proliferation arising on the ear. These cases do not correspond clearly to any recognized category of cutaneous T-cell lymphoma (CTCL) described in the World Health Organization (WHO)/European Organization for Research and Treatment of Cancer (EORTC) 2005 classification. METHODS AND
RESULTS: Three patients (all men; median age 64; range: 61-69) presented with plaques or small tumors localized on the ears. All lesions showed histopathologically a dense, diffuse infiltration of lymphocytes within the entire dermis without epidermotropism. Cytomorphology revealed predominance of medium-sized pleomorphic lymphocytes. Immunohistochemistry showed a cytotoxic phenotype (CD3 + /CD4 -/CD8 +). Polymerase chain reaction (PCR) analysis of the T-cell receptor (TCR)-gamma gene revealed a monoclonal rearrangement in two of three patients. Follow-up data of two patients were available; one is alive without skin or systemic manifestations of the disease after 28 months, whereas the other is alive with persistent skin disease after 7 months.
CONCLUSIONS: Our observation confirms that some patients present with a peculiar lymphoid proliferation of small-medium pleomorphic cytotoxic lymphocytes located on the ear, probably representing a phenotypic variant of the cutaneous small/medium pleomorphic T-cell lymphoma (CSMPTCL). These cases should not be misinterpreted as a high-grade cytotoxic lymphoma.
Copyright © 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2009        PMID: 19602068     DOI: 10.1111/j.1600-0560.2009.01278.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

Review 1.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

Review 2.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

3.  Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience.

Authors:  Pooja Virmani; Sarah Jawed; Patricia L Myskowski; Steven Horwitz; Anna Skripnik Lucas; Alison Moskowitz; Melissa Pulitzer; Jasmine Zain; Steven T Rosen; Christiane Querfeld
Journal:  Int J Dermatol       Date:  2016-11       Impact factor: 2.736

Review 4.  [WHO classification and clinical spectrum of cutaneous lymphomas].

Authors:  C Mitteldorf; S Grabbe; R Stadler
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

5.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

Authors:  Anamarija M Perry; Roger A Warnke; Qinglong Hu; Philippe Gaulard; Christiane Copie-Bergman; Serhan Alkan; Huan-You Wang; Jason X Cheng; Chris M Bacon; Jan Delabie; Erik Ranheim; Can Kucuk; Xiaozhou Hu; Dennis D Weisenburger; Elaine S Jaffe; Wing C Chan
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

Review 6.  Recent advances in cutaneous lymphoma-implications for current and future classifications.

Authors:  J R Goodlad; L Cerroni; S H Swerdlow
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

7.  A Case of an Indolent CD8-Positive Lymphoid Proliferation of the Ear.

Authors:  Banavasi Shanmukha Girisha; Teerthanath Srinivas; Tonita Mariola Noronha; Akshata C Alva; Ashok Menon
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.